Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874299 · ClinicalTrials.gov registry record
The TOGETHER Project - Kidney RNA-seq Validation
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 302
- Enrollment target
NCT03874299: Completed study, sponsored by Mayo Clinic.
NCT03874299 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 302 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03874299 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 302 participants
- Enrollment target
Study Summary
The researchers are trying to develop a way to measure the risk of rejection through the validation of a blood test.
Primary Outcome
The study will validate the ability of a peripheral blood assay to assess the risk of biopsy proven rejection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2016-11-17 |
| Est. Completion | 2019-06-20 |
What the finished NCT03874299 record still lists
NCT03874299 is an observational study that tracks outcomes without assigning an intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03874299 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03874299 about?
NCT03874299 is a clinical study titled "The TOGETHER Project - Kidney RNA-seq Validation". The researchers are trying to develop a way to measure the risk of rejection through the validation of a blood test.
What is the current status of trial NCT03874299?
This trial is currently completed. The enrollment target is 302 participants. The study started on 2016-11-17. Estimated completion is 2019-06-20.
Who is sponsoring clinical trial NCT03874299?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI